[Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences].
Intracoronary brachytherapy is the first internationally recognized, evidence-based coronary intervention for in-stent restenosis. But the present and future role of brachytherapy is questioned by the first results of clinical trials with antiproliferative coated stents. This overview compares the status quo of both methods, concluding first practical considerations.